Unlock the Power of Collaboration with Xentria Meitheal

... Xentria while at Meitheal Pharmaceuticals in a deal valued near $700 million. Jay holds a B.A. in Biology from William Jewell College and an M.B.A. from the ... Tom Shea is the founding President of Xentria and the founding CEO of Meitheal Pharmaceutical, Inc. ... Meitheal Pharmaceuticals was the largest, rare disease focused deal in June. Meitheal gained exclusive rights to commercialize Xentria's ... Xentria is a biotech company building authentic life-sciences partnerships to guide innovative drug and intellectual property development from early ... ... Meitheal's General Counsel & Corporate Secretary since its inception in 2017. In addition, Victoria is the Corporate Secretary of Xentria, Inc. a biotech ... Xentria and Meitheal Pharmaceuticals Announce Exclusive Licensing Agreement for XTMAB-16 in North America. 27 June 2023. Press Release: Positive topline Phase ... Xentria Secures Landmark Agreement with NYU for Cardiovascular Therapy Development. 12/19. iBIO - Illinois Biotechnology Industry Organization · Capital Pulse ... 格隆汇6月27日丨健友股份(603707.SH)公布，公司全资子公司香港健友及香港健友控股子公司Meitheal拟与Xentria签署《许可协议》，Xentria授予被许可方在 ... 健友股份(603707)6月27日晚间公告，公司全资子公司香港健友（被许可方代表）及香港健友控股子公司Meitheal（被许可方）拟与Xentria签署许可协议，Xentria授予被许可方 ... Xentria Secures Landmark Agreement with NYU for Cardiovascular Therapy Development ... The Growing Crisis of Antimicrobial Resistance: Meitheal ... In a significant ...